The Publisher, the industry analysis specialist, has released its latest report Morocco - Healthcare, Regulatory and Reimbursement Landscape. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the Publisher’s team of industry experts.
Morocco is an emerging player in the global pharmaceutical market. In 2019, Morocco's pharmaceutical industry exported around 11% of national production to Europe, America, Asia, and Africa, indicating the importance of this industry, which is ranked second among the African continents after South Africa in terms of quality. In terms of Moroccan Dirhams, the country’s pharmaceutical market increased from MAD 9.31B in 2015 to MAD 13.83B in 2020, at a Compound Annual Growth Rate (CAGR) of 8.2%. In the terms of US dollars, the Moroccan pharmaceutical market increased from $1.02B in 2015 to $1.49B in 2020, at a CAGR of 6.5%. Morocco’s stable political environment and strategic location in the Mediterranean region, which connects Sub-Saharan Africa, the Middle East, and Europe, are intended to alleviate country's pharmaceutical and healthcare industry in the next decade. The medical devices market in Morocco was valued at $270.2M in 2015, which decreased to $240.7M in 2020 at a negative CAGR of 2.3%. Morocco is progressively exploring to develop trade in medical devices and supplies with new partners, including Turkey, Brazil, Argentina, and several Far East countries, all of which can provide a similar quality of devices and supplies at lower costs. In 2018, the Moroccan Telemedicine Society (Société Marocaine de Télémédecine, SMT), in association with the Ministry of Health and Mohammed VI University of Health Sciences, launched a National Telemedicine Initiative with an aim to cover 160 rural municipalities and nearly 2 million population to create a significant health territory by 2025.
The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
This report will enhance your decision-making capability by allowing you to -
Morocco is an emerging player in the global pharmaceutical market. In 2019, Morocco's pharmaceutical industry exported around 11% of national production to Europe, America, Asia, and Africa, indicating the importance of this industry, which is ranked second among the African continents after South Africa in terms of quality. In terms of Moroccan Dirhams, the country’s pharmaceutical market increased from MAD 9.31B in 2015 to MAD 13.83B in 2020, at a Compound Annual Growth Rate (CAGR) of 8.2%. In the terms of US dollars, the Moroccan pharmaceutical market increased from $1.02B in 2015 to $1.49B in 2020, at a CAGR of 6.5%. Morocco’s stable political environment and strategic location in the Mediterranean region, which connects Sub-Saharan Africa, the Middle East, and Europe, are intended to alleviate country's pharmaceutical and healthcare industry in the next decade. The medical devices market in Morocco was valued at $270.2M in 2015, which decreased to $240.7M in 2020 at a negative CAGR of 2.3%. Morocco is progressively exploring to develop trade in medical devices and supplies with new partners, including Turkey, Brazil, Argentina, and several Far East countries, all of which can provide a similar quality of devices and supplies at lower costs. In 2018, the Moroccan Telemedicine Society (Société Marocaine de Télémédecine, SMT), in association with the Ministry of Health and Mohammed VI University of Health Sciences, launched a National Telemedicine Initiative with an aim to cover 160 rural municipalities and nearly 2 million population to create a significant health territory by 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Novartis, Sanofi, and Sothema
- Profiles and SWOT analyses of the major players in the medical device market: Roche Diagnostics, Abbott, Fresenius, Zimmer Biomet, and Air Liquide Healthcare
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement landscape, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Moroccan healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Moroccan healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Table of Contents
1 Table of Contents10. Trade Associations, Morocco11. Trade Fairs, Morocco12. Opportunities and Challenges
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. HealthTech Landscape
8. Market Access
9. Country Healthcare Landscape
13. Appendix
List of Tables
List of Figures
